SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 74.97 |
| Enterprise Value ($M) | 30.07 |
| Book Value ($M) | 88.55 |
| Book Value / Share | 2.23 |
| Price / Book | 0.85 |
| NCAV ($M) | 70.96 |
| NCAV / Share | 1.79 |
| Price / NCAV | 1.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.81 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.72 |
| Current Ratio | 3.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 113.69 |
| Assets | 131.27 |
| Liabilities | 42.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 3.92 | -57.42 | |
| 13G/A | Citadel Advisors Llc | 3.60 | ||
| 13D/A | Vida Ventures GP III, L.L.C. | 12.70 | 0.52 | |
| 13G | Invus Global Management, LLC | 5.30 | ||
| 13G/A | Artal International S.C.A. | 4.90 | 0.00 | |
| 13G/A | Flynn James E | 3.27 | -42.81 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,776 | 48,706 | 3.65 | |
| 10,118 | 92,340 | 10.96 | |
| 14,832 | 153,795 | 9.64 | |
| 16,460 | 1,012,135 | 1.63 | |
| 3,594 | 64,411 | 5.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UBX – Unity Biotechnology, Inc. | UTHR – United Therapeutics Corporation |
| VERV – Verve Therapeutics, Inc. | VIR – Vir Biotechnology, Inc. |
| VOR – Vor Biopharma Inc. |
Financial data and stock pages provided by
Fintel.io